Please enable JavaScript to continue using this application.

Compare $CYRX vs $PACB | Chartloom

Compare

$CYRX vs $PACB

Cryoport Inc · Pacific Biosciences of California Inc

CYRX

Cryoport Inc

PACB

Pacific Biosciences of California Inc

Compare $CYRX vs $PACB

Comparing Cryoport Inc and Pacific Biosciences of California Inc

CYRXCryoport Inc

PACBPacific Biosciences of California Inc

CYRXCryoport Inc

Market cap

$874M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.18x

Rev growth (TTM)

-8.0%

YTD performance

81.5%

52W performance

72.5%

FCF yield

-2.4%

PACBPacific Biosciences of California Inc

Market cap

$724M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.11x

Rev growth (TTM)

2.0%

YTD performance

26.6%

52W performance

54.3%

FCF yield

-18.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CYRX

PACB

Detailed metrics comparison

CYRX

Cryoport Inc

PACB

Pacific Biosciences of California Inc

Market Cap

CYRX$874M

PACB$724M

Enterprise Value

CYRX$793M

PACB$1.31B

Price

CYRX$17.35

PACB$2.33

P/E Ratio

CYRXN/A

PACBN/A

P/S Ratio

CYRX4.69x

PACB4.54x

EV/Sales

CYRX4.25x

PACB8.21x

EV/EBITDA

CYRX1,004.45x

PACB40.33x

P/B Ratio

CYRX1.80x

PACB333.69x

P/FCF Ratio

CYRXN/A

PACBN/A

EV/FCF

CYRX-37.15x

PACB-10.00x

PEG Ratio

CYRXN/A

PACBN/A

Forward P/E (NTM)

CYRXN/A

PACBN/A

Forward P/S (NTM)

CYRX4.18x

PACB4.11x

Revenue (TTM)

CYRX$186M

PACB$159M

Revenue Growth (YoY)

CYRX-8.0%

PACB2.0%

Forward Rev Growth

CYRX8.9%

PACB15.4%

Gross Margin (TTM)

CYRX47.1%

PACB39.2%

Operating Margin (TTM)

CYRX0.0%

PACB0.0%

EBITDA Margin (TTM)

CYRX-7.4%

PACB-88.6%

Net Margin (TTM)

CYRX-24.3%

PACB-82.5%

FCF Margin (TTM)

CYRX-11.4%

PACB-82.0%

Net Income (TTM)

CYRX$-45M

PACB$-131M

FCF (TTM)

CYRX$-21M

PACB$-131M

EPS (TTM)

CYRX-$0.90

PACB-$0.42

ROE (TTM)

CYRX-747.0%

PACB-48845.0%

ROA (TTM)

CYRX-489.0%

PACB-1684.0%

ROIC (TTM)

CYRX-543.0%

PACB-1914.0%

Cash

CYRX$269M

PACB$61M

Debt

CYRX$188M

PACB$644M

Net Cash/Debt

CYRX$81M

PACB$-583M

Current Ratio (TTM)

CYRX2.08x

PACB4.92x

Quick Ratio (TTM)

CYRX1.96x

PACB3.90x

Debt/Equity (TTM)

CYRX0.38x

PACB272.23x

Debt/Assets (TTM)

CYRX0.0%

PACB0.0%

Interest Coverage (TTM)

CYRXN/A

PACBN/A

Net Debt/EBITDA (TTM)

CYRX0.00x

PACB0.00x

Beta

CYRX1.88

PACB2.25

52W Performance

CYRX72.5%

PACB54.3%

YTD Performance

CYRX81.5%

PACB26.6%

% from 52W High

CYRX-5.5%

PACB-32.2%

% from 52W Low

CYRX128.0%

PACB117.8%

Asset Turnover (TTM)

CYRX0.24x

PACB0.20x

FCF Yield (TTM)

CYRX-2.4%

PACB-18.1%

Earnings Yield (TTM)

CYRX-5.2%

PACB-18.2%

Dividend Yield (TTM)

CYRXN/A

PACBN/A

Rule of 40

CYRX-19.5

PACB-80.0

EV/GP/RG

CYRX0.63

PACB1.70

Ticker research

View CYRX research View PACB research

Metric	CYRX Cryoport Inc	PACB Pacific Biosciences of California Inc
Market & Valuation
Market Cap	$874M	$724M
Enterprise Value	$793M	$1.31B
Price	$17.35	$2.33
P/E Ratio	N/A	N/A
P/S Ratio	4.69x	4.54x
EV/Sales	4.25x	8.21x
EV/EBITDA	1,004.45x	40.33x
P/B Ratio	1.80x	333.69x
P/FCF Ratio	N/A	N/A
EV/FCF	-37.15x	-10.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.18x	4.11x
Revenue & Growth
Revenue (TTM)	$186M	$159M
Revenue Growth (YoY)	-8.0%	2.0%
Forward Rev Growth	8.9%	15.4%
Profitability
Gross Margin (TTM)	47.1%	39.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7.4%	-88.6%
Net Margin (TTM)	-24.3%	-82.5%
FCF Margin (TTM)	-11.4%	-82.0%
Net Income (TTM)	$-45M	$-131M
FCF (TTM)	$-21M	$-131M
EPS (TTM)	-$0.90	-$0.42
ROE (TTM)	-747.0%	-48845.0%
ROA (TTM)	-489.0%	-1684.0%
ROIC (TTM)	-543.0%	-1914.0%
Financial Health
Cash	$269M	$61M
Debt	$188M	$644M
Net Cash/Debt	$81M	$-583M
Current Ratio (TTM)	2.08x	4.92x
Quick Ratio (TTM)	1.96x	3.90x
Debt/Equity (TTM)	0.38x	272.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	2.25
52W Performance	72.5%	54.3%
YTD Performance	81.5%	26.6%
% from 52W High	-5.5%	-32.2%
% from 52W Low	128.0%	117.8%
Efficiency & Yields
Asset Turnover (TTM)	0.24x	0.20x
FCF Yield (TTM)	-2.4%	-18.1%
Earnings Yield (TTM)	-5.2%	-18.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-19.5	-80.0
EV/GP/RG	0.63	1.70
Ticker research	View CYRX research	View PACB research

Valuation

P/S Ratio

PACB

4.54x

CYRX

4.69x

EV/FCF

CYRX

-37.15x

PACB

-10.00x

Growth & revenue

Revenue Growth TTM

PACB

2.0%

CYRX

-8.0%

Forward Revenue Growth

PACB

15.4%

CYRX

8.9%

Profitability & performance

Gross Margin

CYRX

47.1%

PACB

39.2%

ROE

CYRX

-747.0%

PACB

-48845.0%

FCF Yield %

CYRX

-2.4%

PACB

-18.1%

52-Week Performance

CYRX

72.5%

PACB

54.3%

Detailed metrics comparison

CYRX

Cryoport Inc

PACB

Pacific Biosciences of California Inc

Market Cap

CYRX$874M

PACB$724M

Enterprise Value

CYRX$793M

PACB$1.31B

Price

CYRX$17.35

PACB$2.33

P/E Ratio

CYRXN/A

PACBN/A

P/S Ratio

CYRX4.69x

PACB4.54x

EV/Sales

CYRX4.25x

PACB8.21x

EV/EBITDA

CYRX1,004.45x

PACB40.33x

P/B Ratio

CYRX1.80x

PACB333.69x

P/FCF Ratio

CYRXN/A

PACBN/A

EV/FCF

CYRX-37.15x

PACB-10.00x

PEG Ratio

CYRXN/A

PACBN/A

Forward P/E (NTM)

CYRXN/A

PACBN/A

Forward P/S (NTM)

CYRX4.18x

PACB4.11x

Revenue (TTM)

CYRX$186M

PACB$159M

Revenue Growth (YoY)

CYRX-8.0%

PACB2.0%

Forward Rev Growth

CYRX8.9%

PACB15.4%

Gross Margin (TTM)

CYRX47.1%

PACB39.2%

Operating Margin (TTM)

CYRX0.0%

PACB0.0%

EBITDA Margin (TTM)

CYRX-7.4%

PACB-88.6%

Net Margin (TTM)

CYRX-24.3%

PACB-82.5%

FCF Margin (TTM)

CYRX-11.4%

PACB-82.0%

Net Income (TTM)

CYRX$-45M

PACB$-131M

FCF (TTM)

CYRX$-21M

PACB$-131M

EPS (TTM)

CYRX-$0.90

PACB-$0.42

ROE (TTM)

CYRX-747.0%

PACB-48845.0%

ROA (TTM)

CYRX-489.0%

PACB-1684.0%

ROIC (TTM)

CYRX-543.0%

PACB-1914.0%

Cash

CYRX$269M

PACB$61M

Debt

CYRX$188M

PACB$644M

Net Cash/Debt

CYRX$81M

PACB$-583M

Current Ratio (TTM)

CYRX2.08x

PACB4.92x

Quick Ratio (TTM)

CYRX1.96x

PACB3.90x

Debt/Equity (TTM)

CYRX0.38x

PACB272.23x

Debt/Assets (TTM)

CYRX0.0%

PACB0.0%

Interest Coverage (TTM)

CYRXN/A

PACBN/A

Net Debt/EBITDA (TTM)

CYRX0.00x

PACB0.00x

Beta

CYRX1.88

PACB2.25

52W Performance

CYRX72.5%

PACB54.3%

YTD Performance

CYRX81.5%

PACB26.6%

% from 52W High

CYRX-5.5%

PACB-32.2%

% from 52W Low

CYRX128.0%

PACB117.8%

Asset Turnover (TTM)

CYRX0.24x

PACB0.20x

FCF Yield (TTM)

CYRX-2.4%

PACB-18.1%

Earnings Yield (TTM)

CYRX-5.2%

PACB-18.2%

Dividend Yield (TTM)

CYRXN/A

PACBN/A

Rule of 40

CYRX-19.5

PACB-80.0

EV/GP/RG

CYRX0.63

PACB1.70

Ticker research

View CYRX research View PACB research

Metric	CYRX Cryoport Inc	PACB Pacific Biosciences of California Inc
Market & Valuation
Market Cap	$874M	$724M
Enterprise Value	$793M	$1.31B
Price	$17.35	$2.33
P/E Ratio	N/A	N/A
P/S Ratio	4.69x	4.54x
EV/Sales	4.25x	8.21x
EV/EBITDA	1,004.45x	40.33x
P/B Ratio	1.80x	333.69x
P/FCF Ratio	N/A	N/A
EV/FCF	-37.15x	-10.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.18x	4.11x
Revenue & Growth
Revenue (TTM)	$186M	$159M
Revenue Growth (YoY)	-8.0%	2.0%
Forward Rev Growth	8.9%	15.4%
Profitability
Gross Margin (TTM)	47.1%	39.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7.4%	-88.6%
Net Margin (TTM)	-24.3%	-82.5%
FCF Margin (TTM)	-11.4%	-82.0%
Net Income (TTM)	$-45M	$-131M
FCF (TTM)	$-21M	$-131M
EPS (TTM)	-$0.90	-$0.42
ROE (TTM)	-747.0%	-48845.0%
ROA (TTM)	-489.0%	-1684.0%
ROIC (TTM)	-543.0%	-1914.0%
Financial Health
Cash	$269M	$61M
Debt	$188M	$644M
Net Cash/Debt	$81M	$-583M
Current Ratio (TTM)	2.08x	4.92x
Quick Ratio (TTM)	1.96x	3.90x
Debt/Equity (TTM)	0.38x	272.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	2.25
52W Performance	72.5%	54.3%
YTD Performance	81.5%	26.6%
% from 52W High	-5.5%	-32.2%
% from 52W Low	128.0%	117.8%
Efficiency & Yields
Asset Turnover (TTM)	0.24x	0.20x
FCF Yield (TTM)	-2.4%	-18.1%
Earnings Yield (TTM)	-5.2%	-18.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-19.5	-80.0
EV/GP/RG	0.63	1.70
Ticker research	View CYRX research	View PACB research